Health
Results: 49-60 of 8661

FDA Grants Breakthrough Therapy Designation to VERTANICAL's VER-01, a First-in-Class Non-Opioid Investigational Treatment for Chronic Low Back Pain

Lundbeck receives orphan drug designation in Japan for asedebart for the treatment of patients with congenital adrenal hyperplasia and Cushing's disease

THREE IN FOUR ALCOHOL DEATHS ARE CAUSED BY LIVER DISEASE. SCOTTISH DEATH RATE REMAINS ONE AND A HALF TIMES ENGLAND'S

Prokarium Reports Positive Interim Data from Phase 1/1b PARADIGM-1 trial of ZH9 in NMIBC patients, Demonstrating Excellent Safety and Encouraging Early Efficacy






